Fragile X Mental Retardation Syndrome: Structure of the KH1-KH2 Domains of Fragile X Mental Retardation Protein

Structure

Volumn 15, Issue 9, 2007, Pages 1090-1098

  Valverde, Roberto ^a   Pozdnyakova, Irina ^a   Kajander, Tommi ^a   Venkatraman, Janani ^a   Regan, Lynne ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

PROTEINS

Indexed keywords

ASPARAGINE; FRAGILE X MENTAL RETARDATION PROTEIN; ISOLEUCINE; PROTEIN KH1; PROTEIN KH2; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DISEASE SEVERITY; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; INCIDENCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 34548430484     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2007.06.022     Document Type: Article

References (40)

1. Adinolfi S., Ramos A., Martin S.R., Dal Piaz F., Pucci P., Bardoni B., Mandel J.L., and Pastore A. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding. Biochemistry 42 (2003) 10437-10444
2. Antar L.N., Dictenberg J.B., Plociniak M., Afroz R., and Bassell G.J. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav. 4 (2005) 350-359
3. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 28 (2005) 235-242
4. Beuth B., Pennell S., Arnvig K.B., Martin S.R., and Taylor I.A. Structure of a Mycobacterium tuberculosis NusA-RNA complex. EMBO J. 24 (2005) 3576-3587
5. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
6. CCP4 (Collaborative Computational Project, Number 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol. Crystallgr. 50 (1994) 760-763
7. Chmiel N.H., Rio D.C., and Doudna J.A. Distinct contributions of KH domains to substrate binding affinity of Drosophila P-element somatic inhibitor protein. RNA 12 (2006) 283-291
8. Cole J.L. Analysis of heterogeneous interactions. Methods Enzymol. 384 (2004) 212-232
9. De Boulle K., Verkerk A.J., Reyniers E., Vits L., Hendrickx J., Van Roy B., Van den Bos F., de Graaff E., Oostra B.A., and Willems P.J. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3 (1993) 31-35
10. DeLano, W.L. (2002). The PyMOL Molecular Graphics System (www.pymol.org).
11. Devys D., Lutz Y., Rouyer N., Bellocq J.P., and Mandel J.L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X permutation. Nat. Genet. 4 (1993) 335-340
12. Eberhart D.E., Malter H.E., Feng Y., and Warren S.T. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5 (1996) 1083-1091
13. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2126-2132
14. Feng Y., Absher D., Eberhart D., Brown V., Malter H., and Warren S. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1 (1997) 109-118
15. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., and Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31 (2003) 3784-3788
16. Git A., and Standart N. The KH domains of Xenopus Vg1RBP mediate RNA binding and self-association. RNA 8 (2002) 1319-1333
17. Gopal B., Haire L.F., Gamblin S.J., Dodson E.J., Lane A.N., Papavinasasundaram K.G., Colston M.J., and Dodson G. Crystal structure of the transcription elongation/anti-termination factor NusA from Mycobacterium tuberculosis at 1.7 Å resolution. J. Mol. Biol. 314 (2001) 1087-1095
18. Grishin N.V. KH domain: one motif, two folds. Nucleic Acids Res. 29 (2001) 638-643
19. Hammond L.S., Macias M.M., Tarleton J.C., and Shashidhar Pai G. Fragile X syndrome and deletions in FMR1: new case and review of the literature. Am. J. Med. Genet. 72 (1997) 430-444
20. Jin P., and Warren S.T. Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 9 (2000) 901-908
21. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 (1991) 110-119
22. Khandjian E.W., Huot M.E., Tremblay S., Davidovic L., Mazroui R., and Bardoni B. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles. Proc. Natl. Acad. Sci. USA 101 (2004) 13357-13362
23. Kleywegt G.J., and Jones T.A. Homo crystallographicus-quo vadis?. Structure 10 (2002) 465-472
24. Lewis H.A., Chen H., Edo C., Buckanovich R.J., Yang Y.Y., Musunuru K., Zhong R., Darnell R.B., and Burley S.K. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Structure 7 (1999) 191-203
25. Lewis H.A., Musunuru K., Jensen K.B., Edo C., Chen H., Darnell R.B., and Burley S.K. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell 100 (2000) 323-332
26. Lo Conte L., Chothia C., and Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285 (1999) 2177-2198
27. Lovell S.C., Davis I.W., Arendall III W.B., de Bakker P.I., Word J.M., Prisant M.G., Richardson J.S., and Richardson D.C. Structure validation by Cα geometry: φ{symbol},ψ and Cβ deviation. Proteins 50 (2003) 437-450
28. Merkel J.S., Sturtevant J.M., and Regan L. Side chain interactions in parallel β sheets: the energetics of cross-strand pairings. Structure 7 (1999) 1333-1341
29. Musco G., Kharrat A., Stier G., Fraternali F., Gibson T.J., Nilges M., and Pastore A. The solution structure of the first KH domain of FMR1, the protein responsible for the fragile X syndrome. Nat. Struct. Biol. 4 (1997) 712-716
30. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
31. Painter J., and Merritt E.A. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62 (2006) 439-450
32. Pozdnyakova I., and Regan L. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level. FEBS J. 272 (2005) 872-878
33. Ramos A., Hollingworth D., Major S.A., Adinolfi S., Kelly G., Muskett F.W., and Pastore A. Role of dimerization in KH/RNA complexes: the example of Nova KH3. Biochemistry 41 (2002) 4193-4201
34. Ramos A., Hollingworth D., Adinolfi D., Castets M., Kelly G., Frenkiel T., Bardoni B., and Pastore A. The structure of the N-terminal domain of the fragile X mental retardation protein: a platform for protein-protein interaction. Structure 14 (2006) 21-31
35. Siomi H., Matunis M.J., Michael W.M., and Dreyfuss G. The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21 (1993) 1193-1198
36. Siomi H., Siomi M.C., Nussbaum R.L., and Dreyfuss G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77 (1994) 33-39
37. Tamanini F., Willemsen R., van Unen L., Bontekoe C., Galjaard H., Oostra B.A., and Hoogeveen A.T. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet. 6 (1997) 1315-1322
38. Terwilliger T.C. SOLVE and RESOLVE: automated structure solution, density modification and model building. J. Synchrotron Radiat. 11 (2004) 49-52
39. Wan L., Dockendorff T.C., Jongens T.A., and Dreyfuss G. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol. Cell. Biol. 20 (2000) 8536-8547
40. Zhang Y.Q., Bailey A.M., Matthies H.J., Renden R.B., Smith M.A., Speese S.D., Rubin G.M., and Broadie K. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107 (2001) 591-603